Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies.
Saved in:
| Title: | Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies. |
|---|---|
| Authors: | Zhang L; Department of Neurology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, Zhejiang, China., Zhang L; Westlake Laboratory (Life Sciences and Biomedicine Zhejiang Laboratory), Hangzhou, 310024, Zhejiang, China., Zhao J; Department of Neurology, Zhoukou Central Hospital, Zhoukou, 466000, Henan, China., Zhang W; Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China., Zhang H; Department of Neurology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, Zhejiang, China. zhanghao@hospital.westlake.edu.cn. |
| Source: | Molecular neurobiology [Mol Neurobiol] 2025 Dec 01; Vol. 63 (1), pp. 231. Date of Electronic Publication: 2025 Dec 01. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
